دورية أكاديمية

Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial.

التفاصيل البيبلوغرافية
العنوان: Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial.
المؤلفون: Stein, Alexander, Paschold, Lisa, Tintelnot, Joseph, Goekkurt, Eray, Henkes, Svenja-Sibylla, Simnica, Donjete, Schultheiss, Christoph, Willscher, Edith, Bauer, Marcus, Wickenhauser, Claudia, Thuss-Patience, Peter, Lorenzen, Sylvie, Ettrich, Thomas, Riera-Knorrenschild, Jorge, Jacobasch, Lutz, Kretzschmar, Albrecht, Kubicka, Stefan, Al-Batran, Salah-Eddin, Reinacher-Schick, Anke, Pink, Daniel
المصدر: JAMA Oncology; Aug2022, Vol. 8 Issue 8, p1150-1158, 9p
قاعدة البيانات: Complementary Index
الوصف
تدمد:23742437
DOI:10.1001/jamaoncol.2022.2228